Range Yourself

RangeYourself · Independent Verification Publisher

We verify what things actually cost, and what you actually get.

RangeYourself is an independent verification publisher that maintains dated, first-party-verified records of what consumer-health programs, AI subscriptions, and business software actually cost, and what you actually get. Price is one axis; we also record what a plan includes, where it ships, and what each vendor states about its own service.

Today that covers 30 GLP-1 telehealth programs, 19 menopause and HRT programs, 30 AI subscriptions, 73 business-software products across 9 categories, and 11 pet insurers. Every price we can obtain publicly is checked by a person against the vendor’s own page and dated per vertical, each vertical’s own date sits on its card below; the most recent check by a person anywhere in our data is September 17, 2026. Across the GLP-1 and menopause programs, an automated check also re-reads those vendors’ pricing pages overnight: on September 21, 2026 it found 34 of those 49 figures still in place. The rest it could not confirm, because the price had moved or the page would not render. That is a staleness check, not a second verification, and every other figure on this site stands on its human date alone. Where no public price exists, we say so rather than estimate.

Or jump to a tool: GLP-1 Cost Calculator · Provider Match Quiz · Flagship GLP-1 comparison

A diverse group of adults exercising together outdoors
  • VerificationEvery price carries its own human-verification date.
  • MonitoringNightly automated audit watches provider sites for drift.
  • IndependenceNo pay-for-play placement. Rank comes from published prices and facts; a payout can only break an exact tie, and the tie is labeled.
  • DisclosureHow we make money is explained on every page.
Jill M. Palko, MD, FACOG

Medical review

Medical review by Jill M. Palko, MD, FACOG

Clinical guidance in our medically reviewed GLP-1 and menopause coverage. Her license number, NPI, and every page she has approved are published on her profile.

Best for…

Cheapest is one axis. Here are the others.

Each card filters on a fact a vendor publishes, then ranks on a real figure inside that filter where one exists; where the filter yields a short list, we name every member. No weighted scores, no paid placement, and where the fact is a vendor’s claim about its own service, we quote it and date it as exactly that.

GLP-1 telehealthVerified August 21, 2026

No state restrictions, ships to all 50 states

Trimi and HealthRX: $99/mo

9 programs state no state exclusion at all on their own site, include medication in the price, and publish that price. 2 share the lowest verified all-in monthly price among them.

See every nationwide program →
GLP-1 telehealthVerified September 16, 2026

Same price at every dose level

HealthRX at $99/mo

4 programs verify "same price at every dose" on their own site, so the maintenance dose costs what the starter dose did. This one holds the lowest verified all-in monthly price among them (12-month plan rate). Flat across doses is not flat across everything: each program's rate is still set by plan term or delivery format, detailed on the page.

See every flat-dose program →
GLP-1 telehealthVerified September 3, 2026

Round-the-clock support, vendor-stated

bmiMD: $119/mo

bmiMD’s own page states “24/7 clinician access, 100% online”, read August 7, 2026. 4 programs state round-the-clock availability on their own pages; 2 of them publish a price, and bmiMD is the lowest of those (the other being Mochi Health). Wellorithm and telos rx publish no recurring price, so they are named here but never price-ranked. Each of these is the vendor’s own claim, quoted and dated. We have not tested any program’s support desk, and a program that says nothing on its page is not a program we say lacks it.

Read our bmiMD review →
NAD+ telehealthVerified July 27, 2026

Cheapest verified prescription NAD+

Enhance MD at $84/mo (sublingual)

9 telehealth programs publish a real, verifiable price for prescription NAD+ (injection, nasal spray, or sublingual), ranked by the cheapest currently-purchasable monthly figure. The winning rate is 12-month plan, billed every 48 weeks ($84/mo headline rate); shorter 1/3/6-month tiers run $89-$99/mo. Compounded NAD+ is not FDA-approved for anti-aging or longevity claims.

Compare every NAD+ program →
AI subscriptionsVerified August 5, 2026

Free plan that grants commercial rights

Adobe Firefly and Ideogram

Of 30 AI tools tracked, 5 state a commercial-use position for their free tier at all, and 2 of those grant commercial rights on the free plan in the vendor’s own terms. Both are counts of what vendors state; a tool that says nothing is recorded as “not stated,” never as a no.

See the per-tool licensing terms →
Amazon PPC softwareVerified August 6, 2026

Complete pricing published, no sales call

m19: $59/mo

3 of 8 Amazon PPC platforms publish enough on their own pages to work out total monthly cost at every ad-spend level we price, without contacting sales. m19 is the cheapest entry point among them.

See who publishes what →
Work-management softwareVerified August 6, 2026

Free plan with no user limit stated

ClickUp and Notion: free, no user limit stated

7 of 8 work-management vendors publish a free plan. 2 of those state no user limit on it at all. The other 5 state a headcount cap on theirs, the largest being Basecamp at 20 users. An unstated limit is what the vendor published, not a promise the tier is unlimited: every free tier still carries its own feature limits, listed per vendor on the page.

Compare every free plan →

One verification standard, 7 verticals

Every vertical below is held to the same rule: a real, currently purchasable price, human-verified against the vendor’s own page and dated, alongside the non-price facts that vendor publishes. GLP-1 is the deepest coverage today, the others are held to the same verification standard as they grow.

Latest stories

All articles →
A woman balancing in a yoga tree pose on a grassy field
GLP-1 Guides

Do GLP-1s Reduce Alcohol Cravings? (2026)

Two randomized trials found semaglutide reduced alcohol craving and heavy drinking days. This is early research, not an FDA-approved use of the drug.

Updated Sep 15, 2026
A jogger on a tree-lined park path on a crisp autumn morning
Health & Weight

GLP-1s in Menopause: Why Weight Loss Slows and Whether HRT Helps

Menopause can genuinely slow GLP-1 weight loss. What the evidence shows about estrogen, energy expenditure, and whether HRT improves semaglutide and tirzepatide results.

Updated Sep 4, 2026
A cyclist on a coastal road, helmet visible
Health & Weight

Testosterone for Women in Menopause: What Is Approved and Who Prescribes It

No testosterone product is FDA-approved for women. What the evidence supports, the September 2026 FDA workshop, and which of 11 online menopause programs prescribe it.

Updated Sep 4, 2026
Friends laughing together at a café table in daylight
GLP-1 Comparisons

Why Am I Losing Weight Slower Than My Husband on the Same GLP-1?

Losing weight slower than your husband on the same GLP-1 medication doesn't mean your dose or hormones are wrong, here's how to separate normal variation, menopause-related factors, and treatment stage.

Updated Jul 21, 2026
A flat-lay overhead shot of an open notebook with a pen and a cup of coffee
GLP-1 Comparisons

My Hunger Comes Back Before My Next GLP-1 Shot: Is That Normal?

Hunger returning a day or two before your next weekly GLP-1 dose can be normal end-of-cycle waning or a sign you're still titrating, here's how to tell the difference and what to track for your prescriber.

Updated Jul 21, 2026
An older woman in a gym, mid-stretch, smiling at the camera
GLP-1 Comparisons

Should I Start HRT Before Starting a GLP-1?

Should you start HRT or a GLP-1 first? A clinician-guided decision framework for sequencing hormone therapy and weight-loss medication safely.

Updated Jul 20, 2026

The reference pages we would point you to first

All GLP-1 coverage →